97 results
Page 4 of 5
8-K
EX-10.2
i2713d
14 Nov 19
AzurRx BioPharma, Inc. Announces Equity Purchase Agreement
9:00am
8-K
EX-10.1
evtym fak
11 Oct 19
AzurRx BioPharma Announces Appointment of James
5:15pm
8-K
EX-10.1
jd6c aiw4qzf1st
14 May 19
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
b8nmdh4
3 Apr 19
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.6
44f37y
20 Feb 19
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
8:29am
8-K
EX-10.3
6e1vo7iqftg57f4qxv6x
20 Feb 19
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
8:29am
8-K
EX-10.4
2bff nre3vywys
20 Feb 19
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
8:29am
8-K
EX-10.2
ybo o6ux3wholt
20 Feb 19
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
8:29am
8-K
EX-10.5
o6mm0karvw8w9b0aj
20 Feb 19
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
8:29am
8-K
EX-10.1
zhgrjoqu6j9f7t2e
20 Feb 19
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
8:29am
8-K
EX-10.1
w9p4jdla
13 Dec 18
AzurRx BioPharma to Acquire Payment Rights to Lead
4:39pm
8-K
EX-10.2
a85c3k y5y
5 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
mgwubs8zrc95y
5 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
w70ggjvh 9hlfj1
2 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
z583wny0pycbgzc
11 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
67d2mr6 zr1
9 Jun 17
AzurRx BioPharma Announces Closing of $5.0 Million Private Financing
12:00am
8-K
EX-10.4
k2xkclb9
9 Jun 17
AzurRx BioPharma Announces Closing of $5.0 Million Private Financing
12:00am